NuCana plc (NASDAQ:NCNA – Get Free Report) was down 2.6% during trading on Monday . The stock traded as low as $3.33 and last traded at $3.36. Approximately 1,704 shares traded hands during trading, a decline of 96% from the average daily volume of 42,891 shares. The stock had previously closed at $3.45.
Analysts Set New Price Targets
Separately, Oppenheimer lifted their price target on NuCana from $4.00 to $150.00 and gave the stock an “outperform” rating in a report on Monday, July 22nd.
Read Our Latest Report on NuCana
NuCana Price Performance
NuCana (NASDAQ:NCNA – Get Free Report) last announced its quarterly earnings data on Thursday, May 16th. The company reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($3.31) by $3.15. On average, equities analysts predict that NuCana plc will post -11.79 earnings per share for the current year.
Hedge Funds Weigh In On NuCana
A hedge fund recently bought a new stake in NuCana stock. Glass Jacobson Investment Advisors llc purchased a new stake in NuCana plc (NASDAQ:NCNA – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 15,000 shares of the company’s stock, valued at approximately $38,000. Glass Jacobson Investment Advisors llc owned about 0.57% of NuCana at the end of the most recent reporting period. Institutional investors own 44.00% of the company’s stock.
About NuCana
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.
Read More
- Five stocks we like better than NuCana
- What is the Dow Jones Industrial Average (DJIA)?
- How to Invest in Silver: A Beginner’s Guide
- What Does a Stock Split Mean?
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Investing in large cap stocks: Diving into big caps
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for NuCana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NuCana and related companies with MarketBeat.com's FREE daily email newsletter.
